Silvia Fallarini

5PUBLICATIONS
16CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 13, 2025
EZH2 Inhibition in Mesothelioma Cells Increases the Release of Extracellular Vesicles That Skew Neutrophils Toward a Protumor Phenotype.

Giulia Pinton, Elia Bari, Silvia Fallarini

|Jul 30, 2025
A Novel Closo-Ortho-Carborane-Based Glucosamine Derivative as a Promising Agent for Boron Neutron Capture Therapy.

Daniela Imperio, Ian Postuma, Salvatore Villani

|Jul 14, 2023
Melanoma Cells Inhibit iNKT Cell Functions via PGE2 and IDO1.

Enza Torre, Giulia Pinton, Grazia Lombardi

|Apr 13, 2023
A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment.

Sara Boumya, Silvia Fallarini, Sonia Siragusa

|Jul 12, 2019
Anomeric sugar boronic acid analogues as potential agents for boron neutron capture therapy.

Daniela Imperio, Erika Del Grosso, Silvia Fallarini

Pageof 1